J. J. Finkelstein, President and CEO at REGENERX BIOPHARMACEUTICALS INC (RGN), bought 5,000 shares at $1.57 ($8K) on 2007-09-06, disclosed to the SEC on 2007-09-07.
Open-market purchase of $8k RGN by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.56 | 900 | $1K | 17.9% |
| 2 | $1.57 | 4,100 | $6K | 82.1% |
| Total | $1.57 avg | 5,000 | $8K | 100% |
| Filing → |